There were 2,049 press releases posted in the last 24 hours and 425,522 in the last 365 days.

Zoll Medical To Buy Alsius Assets

February 23, 2009 (FinancialWire) -- Zoll Medical Corp. (NASDAQ: ZOLL) said that it has signed an agreement with Alsius Corp. (NASDAQ: ALUS) under which Zoll, through a wholly-owned subsidiary, will purchase from Alsius substantially all the assets constituting Alsius's intravascular temperature management device business for $12 million.

The assets to be acquired include the intellectual property relating to the business, other intangibles, inventories and fixed assets. As part of the deal, Zoll will assume warranty obligations relating to Alsius's installed base of products.

Zoll said it plans to consolidate the operations of the acquired business at its facilities in Sunnyvale, California.

Chelmsford, Massachusetts-based Zoll Medical is focused on developing technologies that help advance the practice of resuscitation. The company offers technologies, including Real CPR Help and See-Thru CPR lines, designed to help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims.

Zoll also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

FinancialWire" ( http://www.financialwire.net ), an independent, proprietary news service of Investrend Communications, Inc., receives no compensation for its news or opinions. Further disclosure is at http://www.investrend.com/articles/secondlevel.asp?level=472 . To contact FinancialWire" write to inquiries@financialwire.net .

Free annual reports for companies mentioned in the news are accessible via http://investrend.ar.wilink.com/?level=279 .

Copyright(C)2009 by financialwire.net, Inc. All rights reserved.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.